Document is current
Any future updates will be listed below
-
Authors
Martín Pérez, Carla https://orcid.org/0000-0002-9852-1976
Ramírez-Morros, Anna
Jiménez, Alfons
Vidal, Marta
Pradenas, Edwards https://orcid.org/0000-0001-5162-8920
Barrios, Diana
Canyelles, Mar
Rubio, Rocío https://orcid.org/0000-0002-0448-3404
Cuamba, Inocencia
Izquierdo, Luis https://orcid.org/0000-0002-3704-9874
Santamaria, Pere
Trinité, Benjamin https://orcid.org/0000-0003-3809-042X
Vidal-Alaball, Josep
Molinos-Albert, Luis M. https://orcid.org/0000-0001-5447-6803
Blanco, Julià https://orcid.org/0000-0002-2225-0217
Aguilar, Ruth
Ruiz-Comellas, Anna https://orcid.org/0000-0002-2848-2326
Moncunill, Gemma
Dobaño, Carlota https://orcid.org/0000-0002-6751-4060
- License Information
-
More Information
Article History
Received: 19 November 2024
Accepted: 30 May 2025
First Online: 20 June 2025
Competing interests
: The authors declare the following competing interests: P. Santamaria is founder, scientific officer and stock holder of Parvus Therapeutics and receives funding from the company. He also has a consulting agreement with Sanofi. Carlota Dobaño is an Editorial Board Member for Communications Medicine, but was not involved in the editorial review or peer review, nor in the decision to publish this article. The other authors declare no competing interests.
